In his talk at Targeting Phage Therapy 2024, Prof. Schooley will discuss critical strategies for integrating translational research into clinical trials in phage therapy, ensuring their success and ...

With the global crisis of antibiotic resistance intensifying, phage therapy has emerged as a promising targeted antibacterial strategy and is now entering a critical phase of clinical translation.

Collateral damage to normal microbiota, which can be associated with the use of less-specific chemical antibacterials, [4] is avoided. Nonetheless, there are several challenges that must be addressed ...

With the rapid development of antibiotics in the 1930s, phage therapy—using viruses known as bacteriophages or phages to tackle bacterial infections—fell into oblivion. But as the current rise in ...

Overuse of antibiotics has accelerated the emergence of antimicrobial-resistant (AMR) bacterial species. The World Health Organization named antibacterial resistance as a top public health threat to ...

Christine Carson receives funding from the WA Future Health Research and Innovation Fund, and the CUREator program, a national biotechnology incubator delivered by Brandon BioCatalyst. She has a ...